EVENTS
2021/10/14
患者がん移植ゼブラフィッシュモデル(PDXZ)による定量的腫瘍血管新生阻害薬スクリーニングと作用機構解析
2021/10/13
患者がん移植ゼブラフィッシュモデル(PDXZ)による創薬スクリーニングと個別化医療
2021/10/13
患者がん移植ゼブラフィッシュモデル(PDXZ)による創薬スクリーニングと個別化医療
》Patient-Derived Cancer Xenograft Zebrafish Model (PDXZ) for Quantitative Drug Discovery Screening
2021/10/13
BioJapan2021: Oct 13-15, 2021
We developed novel zebrafish model for patient-derived xenograft (PDXZ), and demonstrated that PDXZ has high rate and speed of engraftment in normal zebrafish when the immune system is immature, requires less than 100 cancer cells for transplantation, and can be quantitatively analyzed in 2 days. We report on drug efficacy screening system that can be quantitatively analyzed within a week.
関連リンク
関連ファイル
Patient-Derived Cancer Xenograft Zebrafish Model (PDXZ) for Quantitative Drug Discovery Screening